Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers

被引:37
作者
Lièvre, A
Landi, B
Côté, JF
Veyrie, N
Zucman-Rossi, J
Berger, A
Laurent-Puig, P
机构
[1] Univ Paris 05, INSERM, UMR, U490,Lab Toxicol Mol S490, F-75006 Paris, France
[2] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Gastroenterol, F-75015 Paris, France
[3] INSERM, U674 Genom Tumeurs Solides, F-75010 Paris, France
[4] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Chirurg Gen Digest & Oncol, F-75015 Paris, France
关键词
colorectal cancer; KLF6; mutation;
D O I
10.1038/sj.onc.1208867
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The KLF6 gene encodes the Kruppel-like factor 6, a transcription factor that has been individualized as a tumor-suppressor gene involved in the regulation of cell proliferation and differentiation. Recently, high frequency (42%) of KLF6 mutations have been reported in colorectal cancers (CRC) as in prostate cancers, astrocytic gliomas and hepatocellular carcinomas. The aims of the study was to confirm the frequency of KLF6 mutations in a larger series of CRC than that previously published by using DNA extracted from frozen tissue samples, which have been proved to generate less mutational artefact than that extracted from formalin-fixed paraffin-embedded tissue samples, in order to compare KLF6 mutation frequency with that of other common genetic alterations and to determine genotype-phenotype correlations. Amplification and direct sequencing of KLF6 exon 2 of 76 CRC and matched normal frozen tissues was performed. Polymorphisms were observed in 14 cases, among which two (T35T and S116S) had not already been reported. No KLF6 somatic mutation was observed. Our data suggest a minor role of KLF6 mutation in colorectal carcinogenesis and underline the fact that the validity of sequence informations obtained from DNA extracted from formalin-fixed tissues may be limited.
引用
收藏
页码:7253 / 7256
页数:4
相关论文
共 34 条
[1]   Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, JR ;
Clarke, PA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (09) :675-684
[2]   Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1 [J].
Benzeno, S ;
Narla, G ;
Allina, J ;
Cheng, GZ ;
Reeves, HL ;
Banck, MS ;
Odin, JA ;
Diehl, JA ;
Germain, D ;
Friedman, SL .
CANCER RESEARCH, 2004, 64 (11) :3885-3891
[3]   Kruppel-like factors: Three fingers in many pies [J].
Bieker, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34355-34358
[4]   Absence of KLF6 gene mutation in 71 hepatocellular carcinomas [J].
Boyault, S ;
Hérault, A ;
Balabaud, C ;
Zucman-Rossi, J .
HEPATOLOGY, 2005, 41 (03) :681-682
[5]  
Chen Han-kui, 2002, Ai Zheng, V21, P1047
[6]  
CHO YG, 2005, ONCOGENE 0411
[7]  
Choi SW, 2002, CLIN CANCER RES, V8, P2311
[8]   In vitro DNA synthesis opposite oxazolone and repair of this DNA damage using modified oligonucleotides [J].
Duarte, V ;
Gasparutto, D ;
Jaquinod, M ;
Cadet, J .
NUCLEIC ACIDS RESEARCH, 2000, 28 (07) :1555-1563
[9]  
Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9
[10]   Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer [J].
Ferraz, JM ;
Zinzindohoué, F ;
Lecomte, T ;
Cugnenc, PH ;
Loriot, MA ;
Beaune, P ;
Stücker, I ;
Berger, A ;
Laurent-Puig, P .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) :183-187